American Oncology Network, Inc.
AONCWDrugs in Pipeline
7
Phase 3 Programs
6
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
Injectafer
Cancer and Chemotherapy Related Anemia
Standard Medical Care (SMC)
Anemia
Ferric Carboxymaltose
Heart Failure
Ferrous Sulfate tablets
Postpartum Anemia
Ferric Carboxymaltose (FCM)
Iron Deficiency Anemia
Venofer
Anemia
Taxoprexin
Metastatic Melanoma
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Injectafer | Phase 3 | Cancer and Chemotherapy Related Anemia | - | - |
Standard Medical Care (SMC) | Phase 3 | Anemia | - | - |
Ferric Carboxymaltose | Phase 3 | Heart Failure | - | - |
Ferrous Sulfate tablets | Phase 3 | Postpartum Anemia | - | - |
Ferric Carboxymaltose (FCM) | Phase 3 | Iron Deficiency Anemia | - | - |
Venofer | Phase 3 | Anemia | - | - |
Taxoprexin | Phase 2 | Metastatic Melanoma | - | - |
Frequently asked questions
What is in American Oncology Network, Inc.'s drug pipeline?→
CatalystAlert tracks 7 drug candidates in American Oncology Network, Inc.'s (AONCW) pipeline across Phase 3, Phase 2. Its lead program is Injectafer (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is American Oncology Network, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for American Oncology Network, Inc. (AONCW) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track AONCW biotech catalysts?→
Add AONCW to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow American Oncology Network, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.